Akso Health Group
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | +101.0% | +0.0% | -1.6% | +31.9% | +24.3% | +16.2% | +102.9% | +40.4% | +104.1% | -36.3% | +87.1% | -93.0% | -47.2% | +117.0% | +18.6% | -7.6% | -80.7% | +1,204.2% | -94.1% | +0.0% | -70.3% | – | – | +0.0% | +2,366.3% | -10.3% | +117.8% | +0.0% | -88.8% | -32.5% | +70.2% | +356.0% | +13.1% | +0.0% | -12.9% | +0.0% | |
| – | – | – | – | – | +58.0% | +2.3% | -14.5% | +4.6% | +42.4% | +68.6% | -35.9% | -33.6% | +59.6% | +3.2% | -28.4% | +20.7% | +14.4% | -95.4% | – | – | -77.4% | +342.1% | – | – | -85.4% | – | – | +2,874.2% | +0.0% | -89.0% | -27.6% | +68.2% | +369.0% | +23.4% | +0.0% | -10.2% | +0.0% | |
| – | 0.0% | +101.0% | +0.0% | -24.8% | +23.9% | +32.9% | +25.6% | +123.2% | +40.2% | +107.6% | -31.2% | +82.1% | -97.1% | -123.2% | – | -28.2% | -22.0% | -66.6% | +1,375.8% | -150.4% | – | – | – | – | -583.3% | – | +208,108,648.8% | -100.0% | +0.0% | -87.3% | -72.9% | +114.5% | +131.4% | -346.1% | – | – | – | |
| – | – | – | +0.0% | +106.0% | +58.0% | +2.3% | -14.5% | +4.6% | +42.4% | +68.6% | -36.0% | -33.4% | +59.6% | +3.2% | +1,081.1% | -92.7% | +14.4% | -97.3% | +8,368.7% | -98.8% | – | – | – | – | 0.0% | -86.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +42.0% | +0.0% | -3.8% | +55.0% | +27.6% | -24.0% | +35.6% | +6.2% | +215.7% | -6.5% | -9.8% | +182.7% | -49.2% | -11.6% | -21.3% | +6.8% | +234.9% | +374.8% | -96.0% | +0.0% | +619.3% | – | – | +0.0% | -64.6% | +499.1% | -92.6% | +0.0% | +1,031.5% | -83.3% | +164.9% | -88.2% | +296.5% | +0.0% | -33.7% | +313.6% | |
| – | 0.0% | +47.6% | +0.0% | -36.6% | +3.5% | +50.8% | +14.3% | +32.9% | +34.0% | +82.8% | -25.7% | +125.3% | +33.1% | -42.8% | -54.3% | +116.2% | +18.0% | +91.2% | +231.7% | -97.0% | +0.0% | +445.2% | – | – | +0.0% | -61.9% | -1,757.6% | – | +0.0% | +2,691.0% | -79.3% | +61.2% | -85.2% | +22,435.6% | +0.0% | -88.7% | +0.0% | |
| – | 0.0% | +305.1% | +0.0% | -8.2% | +43.4% | +20.6% | +35.3% | +189.2% | +42.3% | +115.5% | -39.1% | +87.4% | -148.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +93.9% | -94.6% | +892.1% | +2.1% | – | – | – | -6.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +301.9% | +0.0% | -7.0% | +48.3% | +15.7% | +34.6% | +192.3% | +41.1% | +115.7% | -39.0% | +88.2% | -146.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -95.5% | +0.0% | -987.8% | – | – | – | – | – | – | – | |
| – | +0.0% | +299.9% | +0.0% | -7.0% | +271.7% | +22.9% | -160.6% | – | +33.8% | +135.1% | -52.0% | +189.1% | -92.0% | -167.8% | – | – | +57.4% | -132.1% | – | -99.1% | +0.0% | +452.4% | +0.0% | -95.6% | +0.0% | +534.2% | +6,280.0% | -99.8% | +0.0% | -50.6% | +328.5% | -99.5% | +32,872.9% | +79,164.0% | +0.0% | -106.0% | – | |
| – | +0.0% | +302.2% | +0.0% | -7.0% | +8.7% | +11.3% | +165.5% | +110.3% | +42.4% | +112.2% | -36.6% | +74.1% | -158.6% | – | – | -351.5% | – | – | – | – | – | -143.1% | – | – | – | -123.5% | – | -94.5% | +0.0% | -1,009.2% | – | – | – | – | – | – | – | |
| – | 0.0% | +296.5% | +0.0% | -8.1% | +43.1% | +19.4% | +35.3% | +190.2% | +41.8% | +115.5% | -38.1% | +86.9% | -146.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -101.1% | – | – | – | – | -259.9% | – | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.